T790M的突变富集PCR检测方法和克隆演化假设
Mutant-Enrich PCR Assay in T790M and the Theory of Clone Evolution
摘要
3背景·吉非替尼在临床部分非小细胞肺癌（nonsmall cell lungcancer，NSCLC）患者中取得了较好的疗效．但几乎所有的患者最终将发生耐药。
出处
《循证医学》
CSCD
2008年第4期198-200,共3页
The Journal of Evidence-Based Medicine
参考文献8
-
1Pao W, Miller VA, Politi KA, et al. Acquired resistance of lung adenocarcinomas to Gefitinib or Erlotinib is associated with a second mutation in the EGFR kinase domain[J]. PLoS Med, 2005,2(3) :e73.
-
2Kobayashi S, Boggon TJ, Dayaram T, et al. EGFR mutation and resistance of non-small-cell lung cancer to Gefitinib[J]. N Engl J Med, 2005,352(8) :786-792.
-
3Bean J, Brennan C, Shih JY, et al. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to Gefitinib or Erlotinib[J]. Proc Natl Acad Sci USA, 2007,104(52) :20932-20937.
-
4Yun CH, Mengwasser KE, Toms AV, et al. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP[J]. Proc Natl Acad Sci USA, 2008,105 ( 6 ) : 2070-2075.
-
5Kosaka T, Yatabe Y, Endoh H, et al. Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to Gefitinib [J]. Clin Cancer Res, 2006,12(19) :5764-5769.
-
6Yu Z, Boggon TJ, Kobayashi S, et al. Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies [J]. Cancer Res, 2007,67(21 ) : 10417-10427.
-
7Inukai M, Toyooka S, Ito S, et al. Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer[J]. Cancer Res, 2006, 66(16): 7854-7858.
-
8Ogino A, Kitao H, Hirano S, et al. Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to Gefitinib in a non small cell lung cancer cell line [J]. Cancer Res, 2007,67 (16) : 7807-7814.
-
1王冰,吴侃,张仕蓉,夏冰,马胜林.EGFR-TKI获得性耐药相关T790M突变研究进展[J].浙江临床医学,2015,17(5):845-846.
-
2丁丁,陆舜.T790M在非小细胞肺癌靶向治疗中的作用[J].临床肿瘤学杂志,2014,19(6):560-563. 被引量：2
-
3周清.EGFR突变阳性晚期非小细胞肺癌患者厄洛替尼治疗前的EGFR T790M突变和BRCA1 mRNA表达[J].循证医学,2011,11(1):3-3.
-
4马晓星,王鲁群.用PCR分析30例急性淋巴细胞白血病的克隆演化[J].中华医学遗传学杂志,1996,13(6):350-352.
-
5蔡菁晨,胡俊锋,黎纬明,孙春艳,胡俊斌.存活15年伴克隆3次演化的急性白血病1例[J].临床血液学杂志,2009,22(3):280-281.
-
6徐兵,周淑芸,刘启发,孙竞.两例白血病复发患者的克隆演化[J].中华血液学杂志,1997,18(2):93-94.
-
7徐兵,周淑芸,孙竞,张剑.克隆演化与中枢神经系统白血病复发的关系[J].第一军医大学学报,1998,18(3):199-201. 被引量：2
-
8周率.Wip1和P53在非小细胞肺癌中表达和临床意义[J].临床合理用药杂志,2015,8(23):107-108. 被引量：2
-
9边劲,王琳,寻琛,黄伟.阿法替尼和吉非替尼分别联合培美曲塞对人肺腺癌细胞作用的研究[J].安徽医科大学学报,2014,49(6):772-776. 被引量：9
-
10程颖,郭珑华.非小细胞肺癌中T790M及其对表皮生长因子受体TKI临床疗效的影响[J].循证医学,2013,13(1):30-33. 被引量：1
